Supplemental Material from JAAD Original Article Titled: Comorbid obesity and history of diabetes are independently associated with poorer treatment response to biologics at 6-months: a prospective analysis in the Corrona Psoriasis Registry
This data was collected from patients enrolled in CorEvitas’ Psoriasis Registry from April 2015 through June 2020. Supplemental Table 1: Proportion of patients achieving BSA≤1% and IGA0/1 by drug class and metabolic comorbid disease. Supplemental Table 2. Odds of achieving BSA≤1 and IGA0/1 by drug class and metabolic comorbid disease.